People

Acorda Therapeutics has announced that Chief Technology Officer Rick Batycky is leaving the company as of August 20, 2018 to head up a new private biotech firm. Batycky co-founded Civitas Therapeutics, which was acquired by… Read more . . .

Cohero Health has announced 5 new hires “to scale for growth and drive commercial sales of its BreatheSmart platform.” In 2016, Cohero and H&T Presspart announced that they had partnered on development of an electronic… Read more . . .

Intranasal drug developer Impel NeuroPharma has hired Lynn C. Gold as Senior VP of Regulatory Affairs, the company said. Gold was most recently VP of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services and had… Read more . . .

Former Mylan Senior Director of Inhalation Biopharmaceutics Per Bäckman has joined Emmace Consulting as Senior Inhalation Consultant, the company has announced. Bäckman also previously held various positions at AstraZeneca, including as Principal Scientist in Inhalation… Read more . . .

Galecto Biotech, which is developing an inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), has hired former GSK VP and Head of the Fibrosis & Lung Injury Discovery Performance Unit Richard Marshall… Read more . . .

Liquidia Technologies has named Jeri Thomas as its new Senior VP Commercial, responsible initially for commercial plans for the company’s LIQ861 treprostinil DPI, which is currently in Phase 3 development for the treatment of pulmonary… Read more . . .

TFF Pharmaceuticals, which recently announced that it had raised $14 million for the development of DPI formulations, has named former Arno Therapeutics CEO Glenn Mattes as its new Chief Executive Officer. Mattes’s career includes management… Read more . . .

Swedish instrument company Inhalation Sciences has announced the appointment of Lena Heffler as its new CEO effective May 7, 2018. She will succeed Fredrik Sjövall, who is expected to become Chairman of the Board. Heffler… Read more . . .